HCA Healthcare (HCA) Cost of Revenue (2010 - 2026)

HCA Healthcare has disclosed Cost of Revenue across 17 years of filings, most recently posting $2.9 billion for Q1 2026.

• In Q1 2026, Cost of Revenue fell 25.8% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $17.4 billion (down 3.81% YoY), while the FY2025 annual figure was $15.9 billion, up 7.2% from the prior year.
• Cost of Revenue fell to $2.9 billion in Q1 2026, from $7.5 billion in the prior quarter.
• Over the last five years, Cost of Revenue for HCA reached as high as $7.5 billion in Q4 2025 and fell as low as $2.3 billion in Q1 2022.
• The 5-year median for Cost of Revenue is $2.9 billion (2023), against an average of $3.7 billion.
• Annual changes were most pronounced in 2022 — Cost of Revenue soared 104.81% — and 2026, when it slipped 25.8%.
• A 5-year view of Cost of Revenue shows it stood at $4.2 billion in 2022, then surged by 31.9% to $5.6 billion in 2023, then climbed by 23.39% to $6.9 billion in 2024, then climbed by 9.32% to $7.5 billion in 2025, then tumbled by 61.94% to $2.9 billion in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $2.9 billion, $7.5 billion, and $4.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.